Literature DB >> 23879929

Microcirculation and its relation to continuous subcutaneous glucose sensor accuracy in cardiac surgery patients in the intensive care unit.

Sarah E Siegelaar1, Temo Barwari, Jeroen Hermanides, Peter H J van der Voort, Joost B L Hoekstra, J Hans DeVries.   

Abstract

OBJECTIVE: Continuous glucose monitoring could be helpful for glucose regulation in critically ill patients; however, its accuracy is uncertain and might be influenced by microcirculation. We investigated the microcirculation and its relation to the accuracy of 2 continuous glucose monitoring devices in patients after cardiac surgery.
METHODS: The present prospective, observational study included 60 patients admitted for cardiac surgery. Two continuous glucose monitoring devices (Guardian Real-Time and FreeStyle Navigator) were placed before surgery. The relative absolute deviation between continuous glucose monitoring and the arterial reference glucose was calculated to assess the accuracy. Microcirculation was measured using the microvascular flow index, perfused vessel density, and proportion of perfused vessels using sublingual sidestream dark-field imaging, and tissue oxygenation using near-infrared spectroscopy. The associations were assessed using a linear mixed-effects model for repeated measures.
RESULTS: The median relative absolute deviation of the Navigator was 11% (interquartile range, 8%-16%) and of the Guardian was 14% (interquartile range, 11%-18%; P = .05). Tissue oxygenation significantly increased during the intensive care unit admission (maximum 91.2% [3.9] after 6 hours) and decreased thereafter, stabilizing after 20 hours. A decrease in perfused vessel density accompanied the increase in tissue oxygenation. Microcirculatory variables were not associated with sensor accuracy. A lower peripheral temperature (Navigator, b = -0.008, P = .003; Guardian, b = -0.006, P = .048), and for the Navigator, also a higher Acute Physiology and Chronic Health Evaluation IV predicted mortality (b = 0.017, P < .001) and age (b = 0.002, P = .037) were associated with decreased sensor accuracy.
CONCLUSIONS: The results of the present study have shown acceptable accuracy for both sensors in patients after cardiac surgery. The microcirculation was impaired to a limited extent compared with that in patients with sepsis and healthy controls. This impairment was not related to sensor accuracy but the peripheral temperature for both sensors and patient age and Acute Physiology and Chronic Health Evaluation IV predicted mortality for the Navigator were.
Copyright © 2013 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  23.1; 41.1; APACHE IV PM; Acute Physiology and Chronic Health Evaluation IV predicted mortality; CGM; HI; ICU; IQR; MFI; PPV; PVD; RAD; SDF; StO(2); continuous glucose monitoring; heterogeneity index; intensive care unit; interquartile range; microvascular flow index; perfused vessel density; proportion of perfused vessels; relative absolute deviation; sidestream dark-field; tissue oxygenation

Mesh:

Substances:

Year:  2013        PMID: 23879929     DOI: 10.1016/j.jtcvs.2013.06.017

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  14 in total

1.  Safety of using real-time sensor glucose values for treatment decisions in adolescents with poorly controlled type 1 diabetes mellitus: a pilot study.

Authors:  Larry A Fox; Emilie Balkman; Kim Englert; Jobayer Hossain; Nelly Mauras
Journal:  Pediatr Diabetes       Date:  2016-07-20       Impact factor: 4.866

2.  Glucose Variability Based on Continuous Glucose Monitoring Assessment Is Associated with Postoperative Complications after Cardiovascular Surgery.

Authors:  Hiroki Sato; Michihiro Hosojima; Tomomi Ishikawa; Kenji Aoki; Takeshi Okamoto; Akihiko Saito; Masanori Tsuchida
Journal:  Ann Thorac Cardiovasc Surg       Date:  2017-07-18       Impact factor: 1.520

3.  Accuracy of Continuous Glucose Monitoring in Patients After Total Pancreatectomy with Islet Autotransplantation.

Authors:  Gregory P Forlenza; Brandon M Nathan; Antoinette Moran; Ty B Dunn; Gregory J Beilman; Timothy L Pruett; Boris P Kovatchev; Melena D Bellin
Journal:  Diabetes Technol Ther       Date:  2016-04-22       Impact factor: 6.118

4.  Continuous Glucose Monitor Use and Accuracy in Hospitalized Patients.

Authors:  Vikash Dadlani; Yogish C Kudva
Journal:  Diabetes Technol Ther       Date:  2016-08-08       Impact factor: 6.118

5.  Accuracy of Intra-arterial and Subcutaneous Continuous Glucose Monitoring in Postoperative Cardiac Surgery Patients in the ICU.

Authors:  Marjolein K Sechterberger; Peter H J van der Voort; Paul J Strasma; J Hans DeVries
Journal:  J Diabetes Sci Technol       Date:  2014-12-23

6.  Accuracy and reliability of a subcutaneous continuous glucose monitoring device in critically ill patients.

Authors:  S Rijkenberg; S C van Steen; J H DeVries; P H J van der Voort
Journal:  J Clin Monit Comput       Date:  2017-12-07       Impact factor: 2.502

Review 7.  Glucose control in the ICU: is there a time for more ambitious targets again?

Authors:  Martin Haluzik; Milos Mraz; Petr Kopecky; Michal Lips; Stepan Svacina
Journal:  J Diabetes Sci Technol       Date:  2014-05-18

8.  Accuracy of 2 Different Continuous Glucose Monitoring Systems in Patients Undergoing Cardiac Surgery.

Authors:  Fanny Schierenbeck; Anders Franco-Cereceda; Jan Liska
Journal:  J Diabetes Sci Technol       Date:  2016-07-09

9.  Performance of the Medtronic Sentrino continuous glucose management (CGM) system in the cardiac intensive care unit.

Authors:  Mikhail Kosiborod; Rebecca K Gottlieb; Julie A Sekella; Diane Peterman; Anna Grodzinsky; Paul Kennedy; Michael A Borkon
Journal:  BMJ Open Diabetes Res Care       Date:  2014-07-21

10.  Point accuracy and reliability of an interstitial continuous glucose-monitoring device in critically ill patients: a prospective study.

Authors:  Roosmarijn T M van Hooijdonk; Jan Hendrik Leopold; Tineke Winters; Jan M Binnekade; Nicole P Juffermans; Janneke Horn; Johan C Fischer; Edmée C van Dongen-Lases; Marcus J Schultz
Journal:  Crit Care       Date:  2015-02-05       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.